Implementation Of Track, Trace System For Drug Formulation Exports Extended Till Feb 2024

New Delhi : The government on Friday extended the date for implementation
of the track and trace system for exports of drug formulations till February next year. The decision applies to both non-SSI (Small Scale Industry) and SSI-manufactured drugs.

“The date for implementation of track and trace system for exports of drug formulations with respect to maintaining the parent-child relationship in packaging levels and its uploading on central portal has been extended up to February 1, 2024 for both SSI and non-SSI manufactured drugs,” the Directorate General of Foreign Trade (DGFT) said in a public notice.

Earlier also, the dates have been extended from time to time.

The manufacturer or the exporter of drug formulations would have to print the barcode as per global standards at different packaging levels — primary, secondary and tertiary — to facilitate tracking and tracing of their products.

Barcode helps in tracking and tracing the origin of drugs, which minimises the chances of genuine medicines being considered spurious, sub-standard or counterfeit.

Related Posts

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

India’s pharmaceutical exports rose more than 2% year on year to $31.11 billion in FY26 despite a 23% decline in March amid the fallout of the West Asia war. A…

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS